IPP Bureau
TSCS team met All India Imam Organization Chief to discuss on thalassemia eradication in India
By IPP Bureau - April 04, 2023
Chief Imam of All India Imam Organization, Dr. Imam Umer Ahmed Ilyas, evinces keen interest in the eradication of Thalassemia & Sickle Cell Disease
CBC Group appoints Abbas Hussain as Operating Partner
By IPP Bureau - April 03, 2023
Abbas will closely partner with CBC's business teams to identify, assess, and pursue investment opportunities and strategic acquisitions
GSK and SCYNEXIS announce agreement to commercialise and further develop Brexafemme
By IPP Bureau - April 03, 2023
SCYNEXIS will receive an upfront payment of $90 million with future performance-based milestone payments and tiered royalties
EIP Pharma and Diffusion Pharmaceuticals inks agreement to create CNS-focused company
By IPP Bureau - April 03, 2023
EIP Pharma to initiate in 2Q 2023 a Phase 2b clinical study, funded in part by a $21 million grant from the National Institute of Aging
Immutep announces expansion of triple combination therapy in first-line non-small cell lung cancer
By IPP Bureau - April 03, 2023
Clinical data to date shows efti uniquely positioned to address entire NSCLC patient population through both chemo-free IO-IO and IO-IO-chemo triple combinations
Hutchmed completes rolling submission of NDA to USFDA for fruquintinib
By IPP Bureau - April 03, 2023
NDA supported by data from global Phase III FRESCO-2 study in the U.S., Europe, Japan and Australia along with data from Phase III FRESCO study conducted in China
Apollo Cancer Centres, Navi Mumbai launches 4th gen Da Vinci Xi Robotic Surgical System
By IPP Bureau - April 01, 2023
Launch of the Da Vinci Xi Robotic System is the highlight of the Robotic Colorectal Cancer Symposium organized with the Association of Colon and Rectal Surgeons of India
Alniche Lifesciences expands footprints in respiratory care
By IPP Bureau - April 01, 2023
The upcoming portfolio of respiratory products aims to provide effective solutions for a range of respiratory conditions
Getinge to boost scalability and deepen healthcare access in India
By IPP Bureau - April 01, 2023
Getinge has a strong market share in India within several product segments
HSBC acquisition of SVB UK to unleash new opportunities in biotech sector, finds GlobalData
By IPP Bureau - April 01, 2023
SVB Financial Group and its subsidiaries were involved in over $1.4 billion in total venture financing raised from 2010 to 2022 for drug development
ProBioGen delivers strong 2022 performance
By IPP Bureau - April 01, 2023
ProBioGen was able to carry on its rapid growth trajectory by completing a significantly increased number of projects.
Lonza completes drug product manufacturing line in Visp
By IPP Bureau - March 31, 2023
This expansion follows the groundbreaking of a large-scale commercial drug product facility in Stein (CH), in another milestone for Lonza’s Drug Product Services (DPS) offering
Evonik starts construction of US$220 million lipid innovation center in Lafayette
By IPP Bureau - March 31, 2023
Cooperative agreement with U.S. Government to advance U.S. biopharma industry and ensure pandemic preparedness
MMP Industries wins its first commercial order from Aurobindo Pharma
By IPP Bureau - March 31, 2023
The order marks a significant milestone for MMP Industries that will contribute to the company's revenue in the coming financial year
Alembic receives USFDA final approval for Brimonidine Tartrate Ophthalmic Solution
By IPP Bureau - March 31, 2023
Brimonidine Tartrate Ophthalmic Solution is an alpha adrenergic receptor agonist indicated for the reduction of elevated intraocular pressure
